A bill to direct the Food and Drug Administration to prevent the importation of counterfeit, unapproved, misbranded, or adulterated drugs from the People's Republic of China or other foreign countries, to establish enhanced safeguards for imported drug products, and for other purposes.

This bill would require the Food and Drug Administration (FDA) to take steps to stop fake, unauthorized, or improperly labeled drugs from being brought into the United States from China and other foreign countries, and to put stronger protections in place for drugs that are imported. No official summary is available for this bill.

Your Vote